Therapeutic effect of macular grid photocoagulation in treatment of nonexudative age-related macular degeneration

Archives of Iranian Medicine

Volumn 10, Issue 1, 2007, Pages 14-19

  Nili Ahmadabadi, Mehdi ^a,b   Espandar, Ladan ^a   Mansoori, Mohammad Reza ^a   Karkhane, Reza ^a   Riazi, Mohammad ^a   Ardestani, Ehsanollah ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Laser; Macular degeneration; Photocoagulation; Retinopathy

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUSEN; FEMALE; FOLLOW UP; HUMAN; LASER COAGULATION; MALE; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULOPATHY; SUBRETINAL NEOVASCULARIZATION; TREATMENT FAILURE; TREATMENT OUTCOME; VISUAL ACUITY; VISUAL SYSTEM EXAMINATION;

AGED; AGED, 80 AND OVER; EQUIPMENT DESIGN; EXUDATES AND TRANSUDATES; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; FUNDUS OCULI; HUMANS; LASER COAGULATION; MACULAR DEGENERATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 33846682906     PISSN: 10292977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Klein R, Klein BEK, Jenson SC, Meuer SM. The five-year incidence and progression of age-related maculopathy: The Beaver Dam Eye study. Ophthalmology. 1997; 104: 7-21.
2. Macular Photocoagulation Study Group. Risk factors for choroidal neovascularization in the second eye of patients with juxtafoveal or subfoveal choroidal neovascularization secondary to age-related macular degeneration. Arch Ophthalmol. 1997; 115: 741-747.
3. Holz FG, Wolfensberger TJ, Piguet B, Gross-Jendroska M, Wells JA, Minassian DC, et al. Bilateral macular drusen in age-related macular degeneration. Prognosis and risk factors. Ophthalmology. 1994; 101: 1522-1528.
4. Sigelman J. Foveal drusen resorption one year after perifoveal laser photocoagulation. Ophthalmology. 1991; 98: 1379-1383.
5. Sarks SH, Arnold JJ, Sarks JP, Gilles MC, Walter CJ. Prophylactic perifoveal laser treatment of soft drusen. Aust N Z J Ophthalmol. 1996; 24: 15-26.
6. Figueroa MS, Regueras A,, Bertrand J. Laser photocoagulation to treat macular soft drusen in age-related macular degeneration. Retina. 1994; 14: 391-396.
7. Guymer RH, Gross-Jendroska M, Owens SL, Bird AC, Fitzke FW. Laser treatment in subjects with high-risk clinical features of age-related macular degeneration. Posterior pole appearance and retinal function. Arch Ophthalmol. 1997; 115: 595-603.
8. Little HL, Showman JM, Brown BW. A pilot randomized controlled study on the effect of laser photocoagulation of confluent soft macular drusen. Ophthalmology. 1997; 104: 623-631.
9. Frennesson C, Nilsson SE. Prophylactic laser treatment in early age-related maculopathy reduced the incidence of exudative complications. Br J Ophthalmol. 1998; 82: 1169-1174.
10. The Choroidal Neovascularization Trial Research Group. Laser treatment in eye with large drusen: short-term effect seen in a pilot randomized clinical trial. Ophthalmology. 1998; 105: 11-23.
11. Olk RJ, Friberg TF, Stickney KL, Akduman L, Wong KL, Chen MC, et al. Therapeutic benefits of infrared (810 nm) diode laser macular grid photocoagulation in prophylactic treatment of nonexudative age-related macular degeneration: two-year results of a randomized pilot study. Ophthalmology. 1999; 106: 2082-2090.
12. Frennesson IC, Nilsson SE. Effects of argon (green) laser treatment of soft drusen in early age-related maculopathy: a 6-month prospective study. Br J Ophthalmol. 1995; 79: 905-909.
13. Rodanant N, Friberg TR, Cheng L, Aurora A, Bartsch D, Toyoguchi M, et al. Predictors of drusen reduction after subthreshold infrared (810 nm) diode laser macular grid photocoagulation for nonexudative age-related macular degeneration. Am J Ophthalmol. 2002; 134: 577-585.
14. Kinni M. Prevalence of senile cataract, diabetic retinopathy, senile macular degeneration, and open-angle glaucoma in the Framingham Eye study. Am J Ophthalmol. 1978; 85: 28-34.
15. Leibowitz HM, Krueger DE, Maunder LR, Milton RC, Kini MM, Kahn HA, et al. The Framingham Eye Study monograph: an ophthalmological and epidemiological study of cataract glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973-1975. Surv Ophthalmol. 1980; 24(suppl): 335-610.
16. Mc Cabe FJ, Ho AC. Argon laser to drusen. In: Lim JI, ed. Age-Related Macular Degeneration. 1st ed. New York: Marcel Decker, Inc; 2002: 325-342.
17. Smiddy W, Fine S. Prognosis of patients with bilateral macular drusen. Ophthalmology. 1984; 91: 271-277.
18. Lanchony DM, Maguire MG, Fine SL. A model of the incidence and consequence of choroidal neovascularization secondary to age-related macular degeneration: comparative effects of current treatment and potential prophylaxis on visual outcomes in high-risk patients. Arch Ophthalmol. 1998; 116: 1045-1052.
19. Gass JD. Photocoagulation of macular lesion. Trans Am Acad Ophthalmol Otolaryngol. 1971; 75: 580-608.
20. Duvall J, Tso MO. Cellular mechanisms of drusen after laser coagulation: an experimental study. Arch Ophthalmol. 1985; 103: 694-703.
21. The Choroidal Neovascularization Prevention Trial Research Group. Laser treatment in fellow eyes with large drusen: update findings from a pilot randomized clinical trial. Ophthalmology. 2003; 110: 971-978.
22. The Choroidal Neovascularization Trial Research Group. Choroidal neovascularization in the CNVPT. Ophthalmology. 1998; 105: 1364-1372.
23. Kaiser RS, Berger JW, Maguire MG, Ho AC, Javornik NB. Choroidal Neovascularization Prevention Trial Study Group. Laser burn intensity and risk for choroidal neovascularization in the CNVPT Fellow Eye Study. Arch Ophthalmol. 2001; 119: 826-832.
24. Friberg TP, Musch DC, Lim JI, Morse L, Freeman W, Sinclair S, et al. Prophylactic treatment of age-related macular degeneration report number 1: 810-nanometer laser to eyes with drusen. Unilaterally eligible patients. Ophthalmology. 2006; 113: 622.e1.